Changes in bad phosphorylation are correlated with BCR-induced apoptosis of WEHI-231 immature B cells

Biochimie. 2003 Aug;85(8):733-40. doi: 10.1016/s0300-9084(03)00140-8.

Abstract

Signaling through the B cell antigen receptor (BCR) is a key determinant in the regulation of B cell physiology. Depending on additional factors, such as microenvironment and developmental stage, ligation of the BCR can trigger B lymphocyte activation, proliferation, or apoptosis. The regulatory mechanisms determining B cell apoptosis and survival are not completely known. Using the murine B lymphoma cell line WEHI-231 as a model system, we investigated the role of Bad phosphorylation, a pro-apoptotic member of the Bcl-2 family, in anti-IgM mediated apoptosis. For apoptotic analysis we focused in particular on the mitochondrial potential (deltapsi(m)) collapse which has been reported as a rate-limiting step in the BCR-induced cell death of immature B lymphocytes. Bad phosphorylation at serine 112, 136 and 155 was found in WEHI-231 cell control cultures and its hypophosphorylation on the three sites correlated with the appearance of apoptosis when cross-linking surface IgM. Furthermore, treatment of cells with specific PK inhibitors known to be involved in serine phosphorylation of Bad (LY294002 for PI3K and H-89 for PKA) mimiced or enhanced BCR-induced cell death. These results strongly suggest that regulation of Bad phosphorylation plays an active role in mediating anti-IgM-induced apoptosis of immature B cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 14-3-3 Proteins
  • Animals
  • Apoptosis / physiology*
  • B-Lymphocytes / metabolism*
  • B-Lymphocytes / pathology*
  • Carrier Proteins / metabolism*
  • Cells, Cultured
  • Chromones / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Enzyme Inhibitors / pharmacology
  • Immunoglobulin M / metabolism
  • Isoquinolines / pharmacology
  • Lymphoma, B-Cell
  • Mice
  • Morpholines / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Receptors, Antigen, B-Cell / metabolism*
  • Serine / metabolism
  • Sulfonamides*
  • Tyrosine 3-Monooxygenase / metabolism
  • bcl-Associated Death Protein
  • bcl-X Protein

Substances

  • 14-3-3 Proteins
  • Bad protein, mouse
  • Bcl2l1 protein, mouse
  • Carrier Proteins
  • Chromones
  • Enzyme Inhibitors
  • Immunoglobulin M
  • Isoquinolines
  • Morpholines
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Antigen, B-Cell
  • Sulfonamides
  • bcl-Associated Death Protein
  • bcl-X Protein
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Serine
  • Tyrosine 3-Monooxygenase
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide